How often do you monitor patients on Cosentyx (secukinumab)?
The recommended monitoring frequency for Cosentyx depends on the safety topic being watched (baseline testing vs. ongoing lab and infection surveillance) and on the patient’s risk factors.
What monitoring is typically done before starting?
Before starting Cosentyx, clinicians generally check for key risks such as infection status (including tuberculosis screening) and update relevant immunization and medical history. This baseline step determines how closely patients need follow-up for infection during treatment. [1]
What ongoing monitoring is recommended during treatment?
Ongoing monitoring during Cosentyx therapy focuses on:
- Watching for signs and symptoms of infection.
- Reassessing clinically if new symptoms develop (for example, respiratory symptoms or fever).
- Periodic review of infection history and risk factors.
The monitoring is primarily symptom- and risk-driven rather than a fixed, universal lab schedule. [1]
Does Cosentyx require routine bloodwork at set intervals?
Cosentyx use does not generally follow a rigid, standing “every X weeks/months” blood-test calendar for all patients. Instead, clinicians typically order labs only when clinically indicated (for example, if a patient develops symptoms that suggest an infection or another complication). [1]
How does monitoring differ if the patient is high-risk?
Monitoring tends to be more frequent or more closely targeted if the patient has higher infection risk, known comorbidities, or prior history of tuberculosis or recurrent infections. In those cases, clinicians may increase the intensity of screening and follow-up based on guideline and patient-specific factors. [1]
Where can I verify the exact schedule for my situation?
The most reliable “frequency” is the one in your clinician’s plan or the prescribing information/label monitoring guidance for Cosentyx, because recommendations can vary by indication and patient risk. Confirm the schedule with your prescriber using the product label guidance. [1]
Sources
[1] https://www.cosentyx.com (Cosentyx prescribing information and safety/monitoring guidance)